Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients

por Palich, R., Veyri, M., Marot, S., Vozy, A., Gligorov, J., Maingon, P., Marcelin, A.-G., Spano, J.-P.
Publicado no Ann Oncol (2021)

Upgraded Cobas Ampliprep-Cobas TaqMan Version 2.0 HIV-1 RNA Quantification Assay versus First Version: Correction of Underestimations

por Wirden, M., Tubiana, R., Fourati, S., Thevenin, M., Simon, A., Canestri, A., Ait-Arkoub, Z., Soulie, C., Marcelin, A. G., Katlama, C., Calvez, V.
Publicado em 2011

Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes

por Wirden, M., Tubiana, R., Marguet, F., Leroy, I., Simon, A., Bonmarchand, M., Ait-Arkoub, Z., Murphy, R., Marcelin, A. G., Katlama, C., Calvez, V.
Publicado em 2009

HIV-1 Dynamics and Coreceptor Usage in Maraviroc-Treated Patients with Ongoing Replication

por Recordon-Pinson, P., Raymond, S., Bellecave, P., Marcelin, A. G., Soulie, C., Descamps, D., Calvez, V., Harrigan, P. R., Fleury, H., Izopet, J., Masquelier, B.
Publicado em 2013

Etravirine Concentrations in the Cervicovaginal Compartment in HIV-1-Infected Women Receiving Etravirine-Containing Antiretroviral Therapy: DIVA 02 Study

por Clavel, C., Peytavin, G., Tubiana, R., Soulié, C., Courbon, E., Crenn-Hebert, C., Ichou, H., Blanc, C., Schneider, L., Katlama, C., Marcelin, A.-G., Mandelbrot, L.
Publicado em 2012

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers

por Palich, R., Veyri, M., Vozy, A., Marot, S., Gligorov, J., Benderra, M.-A., Maingon, P., Morand-Joubert, L., Adjoutah, Z., Marcelin, A.-G., Spano, J.-P., Barrière, J.
Publicado no Ann Oncol (2021)